CEO of BioCardia Accumulates 5,000 Shares Amid 55% Stock Drop, Signals Confidence in Turnaround Efforts
BioCardia’s CEO’s steady insider buying signals confidence in a turnaround—learn how his 70% share increase could affect the stock’s future.
3 minutes to read